Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics
- PMID: 14654047
- DOI: 10.1016/j.ab.2003.09.013
Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics
Abstract
Advanced glycation end products (AGEs) accumulate with age and at an accelerated rate in diabetes. AGEs bind cell-surface receptors including the receptor for advanced glycation end products (RAGE). The dependence of RAGE binding on specific biochemical characteristics of AGEs is currently unknown. Using standardized procedures and a variety of AGE measures, the present study aimed to characterize the AGEs that bind to RAGE and their formation kinetics in vitro. To produce AGEs with varying RAGE binding affinity, bovine serum albumin (BSA) AGEs were prepared with 0.5M glucose, fructose, or ribose at times of incubation from 0 to 12 weeks or for up to 3 days with glycolaldehyde or glyoxylic acid. The AGE-BSAs were characterized for RAGE binding affinity, fluorescence, absorbance, carbonyl content, reactive free amine content, molecular weight, pentosidine content, and N-epsilon-carboxymethyl lysine content. Ribose-AGEs bound RAGE with high affinity within 1 week of incubation in contrast to glucose- and fructose-AGE, which required 12 and 6 weeks, respectively, to generate equivalent RAGE ligands (IC50=0.66, 0.93, and 1.7 microM, respectively). Over time, all of the measured AGE characteristics increased. However, only free amine content robustly correlated with RAGE binding affinity. In addition, detailed protocols for the generation of AGEs that reproducibly bind RAGE with high affinity were developed, which will allow for further study of the RAGE-AGE interaction.
Similar articles
-
Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products.Diabetologia. 2004 May;47(5):844-52. doi: 10.1007/s00125-004-1392-9. Epub 2004 May 1. Diabetologia. 2004. PMID: 15127201
-
Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor.Diabetes. 2000 Oct;49(10):1714-23. doi: 10.2337/diabetes.49.10.1714. Diabetes. 2000. PMID: 11016456
-
The biology of the receptor for advanced glycation end products and its ligands.Biochim Biophys Acta. 2000 Dec 20;1498(2-3):99-111. doi: 10.1016/s0167-4889(00)00087-2. Biochim Biophys Acta. 2000. PMID: 11108954 Review.
-
N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins.Biochemistry. 1995 Aug 29;34(34):10872-8. doi: 10.1021/bi00034a021. Biochemistry. 1995. PMID: 7662668
-
Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.Circ Res. 1999 Mar 19;84(5):489-97. doi: 10.1161/01.res.84.5.489. Circ Res. 1999. PMID: 10082470 Review.
Cited by
-
Advanced glycation end products acutely impair ca(2+) signaling in bovine aortic endothelial cells.Front Physiol. 2013 Mar 11;4:38. doi: 10.3389/fphys.2013.00038. eCollection 2013. Front Physiol. 2013. PMID: 23483845 Free PMC article.
-
Role of endocytic inhibitory drugs on internalization of amyloidogenic light chains by cardiac fibroblasts.Am J Pathol. 2006 Dec;169(6):1939-52. doi: 10.2353/ajpath.2006.060183. Am J Pathol. 2006. PMID: 17148659 Free PMC article.
-
Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products.Diabetologia. 2004 May;47(5):844-52. doi: 10.1007/s00125-004-1392-9. Epub 2004 May 1. Diabetologia. 2004. PMID: 15127201
-
Urinary excretion of amino acids and their advanced glycation end-products (AGEs) in adult kidney transplant recipients with emphasis on lysine: furosine excretion is associated with cardiovascular and all-cause mortality.Amino Acids. 2021 Nov;53(11):1679-1693. doi: 10.1007/s00726-021-03091-8. Epub 2021 Oct 24. Amino Acids. 2021. PMID: 34693489 Free PMC article. Clinical Trial.
-
Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway.Antioxid Redox Signal. 2008 Oct;10(10):1699-712. doi: 10.1089/ars.2007.1999. Antioxid Redox Signal. 2008. PMID: 18576917 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources